Ovarian Cancer Symptoms and Treatment

Early Detection Essential In Fight Against Ovarian Cancer

Ovarian cancer is often referred to as the silent killer due to the advanced stage at which most cases are discovered. In the last 30 years, however, medical advancements have allowed us to wage a better fight against the disease, thereby increasing survival rates. As we enter into Ovarian Cancer Awareness Month, experts at Northwestern [...]

Ovarian Cancer Patients Benefit From Telcyta-Pegylated Liposomal Doxorubicin Trial

Telik, Inc. (Nasdaq: TELK) today announced top-line results from an interrupted Phase 3 randomized study of Telcyta (canfosfamide HCL) in combination with pegylated liposomal doxorubicin (PLD) versus PLD alone in second-line therapy in platinum refractory, primary platinum resistant or secondary platinum resistant ovarian cancer. On an intent-to-treat (ITT) basis for the 125 enrolled patients, the [...]

Protein compels ovarian cancer cells to eat themselves

A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 15 issue of Cancer Research. The research team also found that expression of the protein, known as [...]

Ovarian Cancer Cells Are Killed By Platinum-Phosphate Compounds

A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences. The compounds could be less harmful than current cancer treatments on the market [...]

Study Updates Ovarian Cancer Treatment Standard For Women

Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treatment of advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented at the 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in Bangkok in October, has [...]

Mutation of the COX2 gene can double or treble a woman’s risk of ovarian cancer

Ovarian Cancer Risk In Women Researchers in Portugal have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women’s susceptibility to developing ovarian cancer. The discovery raises the possibility that, if the findings are confirmed by further studies, it might be possible to [...]